Review Article
|
Open Access
Featured
-
-
Correspondence
| Open Access
Comment on: “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”
- Spyros I. Papamichos
- & Christof Jungbauer
-
Article
| Open Access
Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer
- Bo-Kyung Kim
- , Soon Woo Nam
- & Misun Won
-
Article
| Open Access
WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer
- Richard J. McGregor
- , You-Ying Chau
- & Patrick W. F. Hadoke
-
Molecular Diagnostics
| Open Access
SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
- H Zhang
- , Y Xu
- & G Giamas
-
Molecular Diagnostics
| Open Access
Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744
- A Vislovukh
- , G Kratassiouk
- & I Groisman
-
Genetics and Genomics
| Open Access
Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells
- S Carbajo-Pescador
- , C Steinmetz
- & S Strand
-
Translational Therapeutics
| Open Access
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
- J Šímová
- , V Polláková
- & M Reiniš
-
Translational Therapeutics
| Open Access
Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
- M Nagata
- , H Nakayama
- & M Shinohara
-
Molecular Diagnostics
| Open Access
Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
- K Armstrong
- , I Ahmad
- & H Y Leung
-
Genetics and Genomics
| Open Access
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
- J Buechner
- , E Tømte
- & C Einvik
-
Genetics and Genomics
| Open Access
Multifunctional transcription factor TFII-I is an activator of BRCA1 function
- M Tanikawa
- , O Wada-Hiraike
- & Y Taketani
-
Translational Therapeutics
| Open Access
PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells
- E N Maginn
- , P V Browne
- & A M McElligott
-
Letter to the Editor
| Open Access
Complexity in the regulation of Dicer expression: Dicer variant proteins are differentially expressed in epithelial and mesenchymal breast cancer cells and decreased during EMT
- G W Hinkal
- , G Grelier
- & C Moyret-Lalle
-
Molecular Diagnostics
| Open Access
Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells
- T Watanabe
- , S Semba
- & H Yokozaki
-
Translational Therapeutics
| Open Access
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma
- L Bodet
- , E Ménoret
- & P Gomez-Bougie
-
Molecular Diagnostics
| Open Access
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
- J C Martin
- , B-S Herbert
- & B A Hocevar
-
Translational Therapeutics
| Open Access
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
- E Di Gennaro
- , G Piro
- & A Budillon
-
Translational Therapeutics
| Open Access
PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
- Y Su
- , M Loos
- & P Büchler
-
Translational Therapeutics
| Open Access
Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
- D E White
- & S A Burchill
-
Genetics and Genomics
| Open Access
Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
- R T Sitaram
- , S Degerman
- & A Li
-
Translational Therapeutics
| Open Access
Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules
- A Körner
- , G Mudduluru
- & H Allgayer
-
Translational Therapeutics
| Open Access
TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy
- S Y Lee
- , S K Luk
- & Y M B Yung
-
Genetics and Genomics
| Open Access
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
- M Eyholzer
- , S Schmid
- & T Pabst
-
Genetics and Genomics
| Open Access
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
- S Lee
- , N Syed
- & T Crook
-
Molecular Diagnostics
| Open Access
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
- G Kristiansen
- , M Rose
- & E Dahl
-
Molecular Diagnostics
| Open Access
Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer
- J J Frietsch
- , T G P Grunewald
- & E Butt
-
Molecular Diagnostics
| Open Access
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
- T Chiyomaru
- , H Enokida
- & M Nakagawa
-
Genetics and Genomics
| Open Access
Identification of DBC1 as a transcriptional repressor for BRCA1
- H Hiraike
- , O Wada-Hiraike
- & Y Taketani
-
Molecular Diagnostics
| Open Access
Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells
- D Mahalingam
- , A Natoni
- & E Szegezdi
